title: Intracranial myeloid sarcoma.
authors.affiliation: Department of Pathology, Wake Forest University, Winston-Salem, NC, USA. dgrier@wfubmc.edu
authors.forename: David D
authors.initials: DD
authors.lastname: Grier
authors.forename: Samer Z
authors.initials: SZ
authors.lastname: Al-Quran
authors.forename: Brian
authors.initials: B
authors.lastname: Gray
authors.forename: Ying
authors.initials: Y
authors.lastname: Li
authors.forename: Raul
authors.initials: R
authors.lastname: Braylan
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D035301:Cranial Fossa, Middle; D003399:Craniotomy; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D023981:Sarcoma, Myeloid / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D019292:Skull Base Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine